Treatment News : High Rate of Bone Problems in French HIV Patients

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » January 2008

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


January 30, 2008

High Rate of Bone Problems in French HIV Patients

French researchers have found rates of serious bone weakness in HIV-positive patients, particularly HIV-positive men, to be many times higher than in the general population’s, according to a new study published in the January 30 issue of AIDS.

Charles Casanave, MD, of the Fédération de Maladies Infectieuses et Tropicales in Bordeaux, France, and his colleagues enrolled 492 patients from a larger group of HIV-positive people being followed in southwestern France known as the Aquitaine Cohort. Seventy-three percent of the patients were men, 70 percent were active smokers—a risk factor for poor bone health—and less than 8 percent took supplemental calcium. The average age was 43 years for men and 41 years for women.

Body mass index (BMI), which is calculated based on a person’s height and weight, was available for 482 participants, 24 percent of whom had a BMI of less than 20, which is considered low and is a further risk factor for poor bone health. The vast majority of participants, 93 percent, were on combination antiretroviral therapy.

In order to diagnose osteopenia—a moderate reduction in bone mineral density—and osteoporosis—a more severe reduction in bone mineral density that can increase the risk of a serious fracture—Casanave’s team conducted dual energy X-ray absorptiometry (DEXA) scans on the participants’ spines and femurs, the large leg bone that links to the hip.

Fifty-five percent of the men in the study and 51 percent of the women were diagnosed with osteopenia. Thirty-four percent of the men and 8 percent of the women were diagnosed with the more serious osteoporosis. Other studies of bone health in people living with HIV have found rates of osteoporosis of 15 percent, which is almost four times higher than in similar people who are HIV negative.

Factors associated with osteopenia and osteoporosis in men included having acquired HIV through sex with other men and having an undetectable viral load. Men whose CD4 counts had ever been particularly low, known as the CD4 nadir, were also at greatest risk of osteopenia. The authors theorized that rates may have been higher in gay men because of higher rates of substance use in this community and higher rates of infection with herpes virus type 8 and Kaposis sarcoma, which can affect bone health.

In women, older age and low CD4 nadir were associated with a greater risk of having osteopenia or osteoporosis.

When measured directly, antiretroviral therapy was not associated with an increased risk for either disorder. Casanave’s team reasoned, however, that an undetectable viral load and low CD4 nadir both occur most commonly in people who’ve been on antiretroviral therapy and thus may point to some contribution of the meds on people’s bone health.

Casanave’s team also explains that the extremely high rates of osteoporosis found among the men in the study may be at least partially explained by the fact that the DEXA scans of the men had to be compared to samples from men in the United States, who on average consume more calcium than French men. The team is calling for more research to accurately determine how prevalent bone problems are in people living with HIV and what risk factors most contribute to those problems.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (2 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.